Dganit Bar
CEO
Claimed by owner Sentaur Biosciences
Former names: EXPLORE BIO 3
Developing Antibodies to Target Senescent Cells
Sentaur Biosciences
About
Sentaur Biosciences is developing antibodies designed to specifically eliminate senescent cells by identifying novel targets on the surface of the cells.
The companys technology comes from the lab of Professor Valery Krizhanovsky, a world renown expert in the field of senescent cells at the Weizmann Institute.
The companys technology comes from the lab of Professor Valery Krizhanovsky, a world renown expert in the field of senescent cells at the Weizmann Institute.
Employees
Product stage
Primary Sector
Life Sciences & HealthTech
Products
-
Geographic markets
-
Funding
Total Funding
Undisclosed
Last Funding
Undisclosed
Funding Stage
Total Rounds
1
Investors
2
News
(0)The Team
(2)
DB
VK
Valery Krizhanovsky
Founder
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Private Equity Funding
Undisclosed Round
Undisclosed
Jun 2018
2 Investors
Undisclosed
Others
Academic Techonology
Mar 2018
undefined
A unique MS based discovery method to identify novel targets onto the surface of senescence cells
Media gallery
(0)Locations
Israel
Yavne, Israel
Locations
Israel
Yavne, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,